A detailed history of Mai Capital Management transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Mai Capital Management holds 63,456 shares of EW stock, worth $4.16 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
63,456
Previous 61,993 2.36%
Holding current value
$4.16 Million
Previous $5.92 Million 1.06%
% of portfolio
0.06%
Previous 0.06%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$84.3 - $94.31 $123,330 - $137,975
1,463 Added 2.36%
63,456 $5.86 Million
Q1 2024

May 08, 2024

BUY
$72.54 - $95.56 $116,789 - $153,851
1,610 Added 2.67%
61,993 $5.92 Million
Q4 2023

Feb 09, 2024

BUY
$61.71 - $77.76 $3.07 Million - $3.87 Million
49,772 Added 469.06%
60,383 $4.6 Million
Q3 2023

Nov 14, 2023

BUY
$69.28 - $93.38 $24,317 - $32,776
351 Added 3.42%
10,611 $735,000
Q2 2023

Aug 02, 2023

SELL
$81.41 - $94.33 $40,949 - $47,447
-503 Reduced 4.67%
10,260 $967,000
Q1 2023

May 10, 2023

BUY
$74.26 - $84.51 $117,776 - $134,032
1,586 Added 17.28%
10,763 $890,000
Q4 2022

Feb 09, 2023

SELL
$68.3 - $87.44 $11,201 - $14,340
-164 Reduced 1.76%
9,177 $684,000
Q3 2022

Nov 15, 2022

SELL
$82.37 - $107.29 $104,774 - $136,472
-1,272 Reduced 11.99%
9,341 $772,000
Q2 2022

Jul 19, 2022

BUY
$86.5 - $128.27 $83,299 - $123,524
963 Added 9.98%
10,613 $1.01 Million
Q1 2022

May 10, 2022

BUY
$101.96 - $128.34 $66,681 - $83,934
654 Added 7.27%
9,650 $1.14 Million
Q4 2021

Feb 11, 2022

BUY
$106.37 - $130.68 $560,357 - $688,422
5,268 Added 141.31%
8,996 $1.17 Million
Q3 2021

Nov 12, 2021

BUY
$102.91 - $122.75 $77,799 - $92,799
756 Added 25.44%
3,728 $422,000
Q2 2021

Jul 19, 2021

BUY
$83.84 - $104.76 $7,210 - $9,009
86 Added 2.98%
2,972 $308,000
Q1 2021

May 10, 2021

BUY
$78.68 - $90.67 $12,274 - $14,144
156 Added 5.71%
2,886 $241,000
Q4 2020

Feb 16, 2021

SELL
$71.69 - $91.23 $8,674 - $11,038
-121 Reduced 4.24%
2,730 $249,000
Q3 2020

Oct 26, 2020

SELL
$67.19 - $87.44 $50,930 - $66,279
-758 Reduced 21.0%
2,851 $228,000
Q2 2020

Jul 27, 2020

BUY
$57.54 - $76.95 $140,455 - $187,834
2,441 Added 208.99%
3,609 $249,000
Q1 2020

Apr 16, 2020

BUY
$52.41 - $81.0 $7,651 - $11,826
146 Added 14.29%
1,168 $220,000
Q4 2019

Feb 03, 2020

BUY
$71.7 - $82.09 $71 - $82
1 Added 0.1%
1,022 $238,000
Q3 2019

Oct 29, 2019

BUY
$61.55 - $75.43 $62,842 - $77,014
1,021 New
1,021 $225,000
Q2 2019

Aug 15, 2019

SELL
$55.74 - $64.41 $59,474 - $68,725
-1,067 Closed
0 $0
Q1 2019

Apr 29, 2019

BUY
$47.89 - $64.05 $51,098 - $68,341
1,067 New
1,067 $204,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Mai Capital Management Portfolio

Follow Mai Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mai Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Mai Capital Management with notifications on news.